Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  D DERMATOLOGICALS
    D11 OTHER DERMATOLOGICAL PREPARATIONS
      D11A OTHER DERMATOLOGICAL PREPARATIONS
        D11AH Agents for dermatitis, excluding corticosteroids
          D11AH04 Alitretinoin
            D02815  Alitretinoin (USAN) <US>
  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
    L01 ANTINEOPLASTIC AGENTS
      L01X OTHER ANTINEOPLASTIC AGENTS
        L01XF Retinoids for cancer treatment
          L01XF02 Alitretinoin
            D02815  Alitretinoin (USAN) <US>

USP drug classification [BR:br08302]
  Antineoplastics
    Retinoids
      Alitretinoin
        D02815  Alitretinoin (USAN)

Drug groups [BR:br08330]
  Vitamin and mineral
    DG01604  Retinol derivative
      D02815  Alitretinoin

Target-based classification of drugs [BR:br08310]
  Nuclear receptors
    Thyroid hormone like receptors
      Retinoic acid receptor (RAR)
        NR1B (RAR) [HSA:5914 5915 5916] [KO:K08527 K08528 K08529]
          D02815  Alitretinoin (USAN) <US>
    Hepatocyte nuclear factor 4 like receptors
      Retinoid X receptor (RXR)
        NR2B (RXR) [HSA:6256 6257 6258] [KO:K08524 K08525 K08526]
          D02815  Alitretinoin (USAN) <US>

New drug approvals in the USA [br08319.html]
  D02815

New drug approvals in Europe [br08329.html]
  D02815

New drug approvals in the USA, Europe and Japan [br08328.html]
  D02815